Professor András Szász is a biophysicist. His research interests are in the bioelectrodynamics applications of fractal physiology and biocomplexity. He was teaching for 50+ years in numerous universities, currently retired. His extensive scientific work is evidenced by more than 200 scientific publications, including articles, conference proceedings, and eight books. Professor Szász is the leading developer of "oncothermia" (modulated electrohyperthermia, mEHT), an innovative oncology therapy. Recognizing the application possibilities, he founded a university spin-off company in Hungary in 1988, which later became Oncotherm Ltd., and was engaged in the design and production of mEHT devices. To further strengthen this technology, he also founded the German company Oncotherm GmbH for marketing purposes. The mEHT method has achieved significant global spread, currently approved and used in more than 30 countries, providing 500,000+ treatments annually. Professor Szász is the Chief Scientific Officer of the Oncotherm Group (www.oncotherm.com), overseeing research and development for both the Hungarian and German organizations.